Large Study Links GLP-1s to Lower Risk of Multiple Cancers
Patients taking GLP-1 receptor agonists for weight loss had a 41% lower risk of obesity-associated cancers compared with patients prescribed diet or exercise. Patients taking tirzepatide had substantially greater cancer…
